July 09, 2015
Jupiter, FL DMG Productions announced today that it will feature Genomind, Inc. in an upcoming episode of Innovations, airing later this year (2015), via the Discovery Channel.
This segment will focus on Genomind, a personalized medicine company bringing innovation to mental healthcare through genetic testing. Genomind is comprised of pioneering researchers and thought leaders in psychiatry and neurology and specializes in pharmacogenetic laboratory testing for psychiatry. Innovations will educate on how Genomind is committed to partnering with clinicians in the field of psychiatry to improve their patients lives.
The show will teach viewers about personalized medicine in psychiatry through pharmacogenetic testing. Audiences will learn how certain genetic variations are being detected in patients and then used to create optimized treatment plans for the individual. Having this specific genetic information on a patient can decrease the timeline to finding the right treatment and can help to avoid unwanted side effects and adverse reactions. Ultimately, this decreases overall patient suffering and can save lives. Genominds testing has been shown to decrease overall healthcare costs as well. As such, Genominds testing can help the clinician be more successful in their quest to heal patients.
We are excited to be featured by Innovations TV as a cutting-edge life sciences company, and to increase awareness among clinicians and patients of our Genecept Assay. Education is an important part of our mission at Genomind to improve patients lives, and our participation in this TV show will help to educate the public on what we do every day, said Michael Koffler, Genominds President and Chief Executive Officer.
With a commitment to bringing science to psychiatry and to creating new innovations that will help clinicians improve their patients lives, Genomind partners with leaders from the worlds most prestigious institutions, said Jake Meiteles, Producer for the Series. We look forward to educating audiences on how Genomind is at the forefront of personalized medicine in psychiatry.
Genomind is a personalized medicine company bringing innovation to mental healthcare through genetic testing. Genomind is comprised of pioneering researchers and thought leaders in psychiatry and neurology and specializes in pharmacogenetic laboratory testing for psychiatry. Genomind is committed to partnering with clinicians to improve their patients lives.
The Genecept Assay is a genetic test offered by Genomind, designed to help clinicians optimize treatment decisions for their patients with mental illness. It identifies patient-specific genetic markers that indicate which treatments are likely to work as intended, have no effect, or cause adverse effects. It is an easily administered cheek swab test that analyzes key genes, selected based on hundreds of studies showing that variations in these genes can inform treatment decisions. The Assay is used to guide treatment for a range of psychiatric conditions including depression, anxiety, ADHD, bipolar disorder, PTSD and schizophrenia, and has been shown in peer reviewed published studies to improve patient outcomes and reduce overall medical costs. Each Assay provides clinicians with an easy to read patient report and a complimentary psychopharmacologist consultation. Learn more at http://www.genomind.com.
About Innovations and DMG Productions:
Innovations, hosted by award winning actor Ed Begley, Jr., is an information-based series geared toward educating the public on the latest breakthroughs in all areas of society. Featuring practical solutions and important issues facing consumers and professionals alike, Innovations focuses on cutting-edge advancements in everything from health and wellness to global business, renewable energy, and more.
DMG Productions (responsible for creating the Innovations show) includes personnel specialized in various fields from agriculture to medicine, independent films to regional news and more. Field producers work closely with experts in the field to develop stories. This powerful force enables DMG to consistently produce commercial-free, educational programming that both viewers and networks depend on.
For more information visit: http://www.InnovationsTelevision.com or contact Jake Meiteles at: (866) 496-4065 x 830 or via email at: Jake(at)InnovationsTelevision(dot)com.
Find More Work Study Press Releases